| Systematic review: the effect on surrogates of making treatment decisions for others D Wendler, A Rid Annals of internal medicine 154 (5), 336-346, 2011 | 845 | 2011 |
| Ethical considerations of experimental interventions in the Ebola outbreak A Rid, EJ Emanuel The Lancet 384 (9957), 1896-1899, 2014 | 167 | 2014 |
| A framework for risk-benefit evaluations in biomedical research A Rid, D Wendler Kennedy Institute of Ethics Journal 21 (2), 141-179, 2011 | 162 | 2011 |
| Evaluating the risks of clinical research A Rid, EJ Emanuel, D Wendler Jama 304 (13), 1472-1479, 2010 | 159 | 2010 |
| Ethics of controlled human infection to address COVID-19 SK Shah, FG Miller, TC Darton, D Duenas, C Emerson, HF Lynch, ... Science 368 (6493), 832-834, 2020 | 149 | 2020 |
| Universal health coverage, priority setting, and the human right to health B Rumbold, R Baker, O Ferraz, S Hawkes, C Krubiner, P Littlejohns, ... The Lancet 390 (10095), 712-714, 2017 | 135 | 2017 |
| Rescue of the mineralocorticoid receptor knock-out mouse M Bleich, R Warth, M Schmidt-Hieber, A Schulz-Baldes, P Hasselblatt, ... Pflügers Archiv 438 (3), 245-254, 1999 | 119 | 1999 |
| Systematic review: individuals' goals for surrogate decision‐making B Kelly, A Rid, D Wendler Journal of the American Geriatrics Society 60 (5), 884-895, 2012 | 118 | 2012 |
| Research led by participants: a new social contract for a new kind of research E Vayena, R Brownsword, SJ Edwards, B Greshake, JP Kahn, N Ladher, ... Journal of Medical Ethics 42 (4), 216-219, 2016 | 113 | 2016 |
| Standards of practice in empirical bioethics research: towards a consensus J Ives, M Dunn, B Molewijk, J Schildmann, K Bærøe, L Frith, R Huxtable, ... BMC medical ethics 19 (1), 68, 2018 | 109 | 2018 |
| Justice and procedure: how does “accountability for reasonableness” result in fair limit-setting decisions? A Rid Journal of Medical Ethics 35 (1), 12-16, 2009 | 107 | 2009 |
| Disclosure of incidental findings from next-generation sequencing in pediatric genomic research R Abdul-Karim, BE Berkman, D Wendler, A Rid, J Khan, T Badgett, ... Pediatrics 131 (3), 564-571, 2013 | 97 | 2013 |
| Use of a patient preference predictor to help make medical decisions for incapacitated patients A Rid, D Wendler Journal of Medicine and Philosophy 39 (2), 104-129, 2014 | 95 | 2014 |
| A personalized patient preference predictor for substituted judgments in healthcare: Technically feasible and ethically desirable BD Earp, S Porsdam Mann, J Allen, S Salloch, V Suren, K Jongsma, ... The American Journal of Bioethics 24 (7), 13-26, 2024 | 87 | 2024 |
| Placebo use in vaccine trials: recommendations of a WHO expert panel A Rid, A Saxena, AH Baqui, A Bhan, J Bines, MC Bouesseau, A Caplan, ... Vaccine 32 (37), 4708-4712, 2014 | 82 | 2014 |
| In defense of a social value requirement for clinical research D Wendler, A Rid Bioethics 31 (2), 77-86, 2017 | 81 | 2017 |
| Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies EJ Emanuel, G Bedarida, K Macci, NB Gabler, A Rid, D Wendler bmj 350, 2015 | 80 | 2015 |
| Can we improve treatment decision‐making for incapacitated patients? A Rid, D Wendler Hastings Center Report 40 (5), 36-45, 2010 | 79 | 2010 |
| The 2008 Declaration of Helsinki—First among equals in research ethics? A Rid, H Schmidt Journal of Law, Medicine & Ethics 38 (1), 143-148, 2010 | 72 | 2010 |
| Risks of phase I research with healthy participants: a systematic review RA Johnson, A Rid, E Emanuel, D Wendler Clinical Trials 13 (2), 149-160, 2016 | 65 | 2016 |
David WendlerSenior Researcher, NIHVerified email at nih.gov
